Drug factory · FDA FEI 3027022725

Wellbeing Medical Supply

3151 Airway Ave Ste I2, Costa Mesa, CA, United States

Problems found, fixed voluntarily at FDA's last inspection, Apr 25, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

1 drug inspection on record since 2025: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

Drug	Role	For	NDC
Benzalkonium and Furosemide	Packages it	Wellbeing Medical Supply	83315-100, 83315-200

Ended	Result	Program	Problems noted
Apr 25, 2025	Problems found, fixed voluntarily	Drug Quality Assurance	4

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Procedures are written, and followed 21 CFR 211.130
Procedures designed to assure that correct labels, labeling and packaging materials are used for drug products are not written.
Records not made readily available to FDA 21 CFR 211.180(c)
Records associated with drug product production and distribution and within the retention period for such records, were not made readily available for authorized inspection.
Complaint Handling Procedure 21 CFR 211.198(a)
Procedures describing the handling of written and oral complaints related to drug products are not written or followed.
Training--operations, GMPs, written procedures 21 CFR 211.25(a)
Employees are not given training in the particular operations they perform as part of their function.

Registered with FDA for: pack.